DEERFIELD, Ill., Jan. 17, 2017 -- Mondelēz International, Inc. will release its fourth quarter and full-year 2016 financial results on Tuesday, Feb. 7, at 4 p.m. ET and will host a conference call at 5 p.m. ET that day.
Investors and analysts may participate via phone by calling 1-800-322-9079 from the United States and 1-973-582-2717 from other locations. To ensure timely access, participants should dial in approximately 10 minutes before the call starts. A listen-only webcast will be provided at www.mondelezinternational.com.
A replay of the conference call will be available until Feb. 21, 2017, by calling 1-855-859-2056 from the United States and 1-404-537-3406 from other locations. The access code for both the conference call and its rebroadcast is 49173919. An archive of the webcast will be available on the company's website.
Mondelēz International will also present at the annual Consumer Analyst Group of New York (CAGNY) Conference in Boca Raton, Fla., on Feb. 21 at 1:45 p.m. ET. Access to a live audio webcast with accompanying slides will be available at www.mondelezinternational.com and a replay of the event will also be available on the company's website.
The company will be live tweeting from both events at www.twitter.com/MDLZ.
About Mondelēz International
Mondelēz International, Inc. (NASDAQ:MDLZ) is a global snacking powerhouse, with 2015 net revenues of approximately $30 billion. Creating delicious moments of joy in 165 countries, Mondelēz International is a world leader in biscuits, chocolate, gum, candy and powdered beverages, with billion-dollar brands, such as Oreo, LU and Nabisco biscuits; Cadbury, Cadbury Dairy Milk and Milka chocolate; and Trident gum. Mondelēz International is a proud member of the Standard and Poor's 500, NASDAQ 100 and Dow Jones Sustainability Index. Visit www.mondelezinternational.com or follow us on Twitter at www.twitter.com/MDLZ.
Contact: Michael Mitchell (Media) +1 847 943 5678 [email protected] Shep Dunlap (Investors) +1 847 943 5454 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Italy Fines Apple €98.6 Million Over App Store Dominance
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 



